USA Healthcare News Updates

 The global  neuromodulation devices market  size is projected to reach USD 9.34 billion by 2026, exhibiting a CAGR of 9.5% during the forecast period. Steady climb in the prevalence of chronic conditions across the globe will be a key factor fueling the growth of this market, observes Fortune Business Insights™ in its report, titled “Neuromodulation Devices Market Size, Share & Industry Analysis, By Product Type (Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Vagus Nerve Stimulators (VNS), Sacral Nerve Stimulators (SNS), Transcranial Magnetic Stimulators (TMS), and Others), By Type (Invasive, and Non-invasive), By Application (Pain Management, Neurological Disorders, Respiratory Disorders, and Others), By End User (Hospitals, and Specialty Clinics), and Regional Forecast, 2019-2026”. Chronic conditions or non-communicable diseases (NCDs), such as sleep apnea and epilepsy, can be understood as complications in health that affect the normal functioning of...

According to Fortune Business Insights, the global  autonomous last mile delivery market size  is projected to grow from USD 11.12 billion in 2021 to USD 51.38 billion in 2028, at CAGR of 24.4% during forecast period. This information is presented by Fortune Business Insights™, in its report titled, “Autonomous Last Mile Delivery Market, 2021-2028.” Request a Sample Copy of the Research Report:  https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/autonomous-last-mile-delivery-market-105598 Segmentation Vehicle Type, Solution, Range, and Region are Studied On the basis of vehicle type, the market is classified into aerial delivery drones, ground delivery bots, and self-driving trucks & vans. The ground delivery bots segment holds the major share in the global market. By solution, the market is categorized into hardware, software, and services. In terms of range, the market is divided into long-range and short-range. Geographically, the ma...

The global non-small cell lung cancer therapeutics market is growing impressively due to recent surge in adoption of targeted therapy for treating non-small cell lung cancer. According to a report published by  Fortune Business Insights , titled  ‘ Non-Small Cell Lung Cancer Therapeutics Market : Global Market Analysis, Insights and Forecasts, 2019-2026,’  the market value will rise substantially from US$ 16,011.7 Mn in 2018 to US$ 43,713.1 Mn by 2026. Fortune Business Insights has further predicted the market to exhibit an impressive CAGR of 13.4% between 2019 and 2026 due to exceptional advancements in targeted therapy in recent years. Such high growth can be attributable to the increasing demand for chemotherapy and targeted therapy. Furthermore, advantages of targeted therapy over other alternatives are in plenty. Driven by this, the demand for targeted therapy for diagnosis will increase, which in turn spurs growth in the global non-small cell lung cancer therapeutic...

 The global  critical care antiarrhythmic drugs market  size is projected to reach USD 1,319.7 million by 2027, exhibiting a CAGR of 5.6% during the forecast period. Increasing prevalence of cardiovascular diseases (CVDs) around the world will be a major growth determinant for this market, highlights Fortune Business Insights™ in its report, titled “Critical Care Antiarrhythmic Drugs Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Beta Blockers, Calcium Channel Blockers, Sodium Channel Blockers, Potassium Channel Blockers, and Others),  By Disease Type (Supraventricular Arrhythmias, Ventricular Arrhythmias, and Others), and Regional Forecast, 2020-2027”. According to the World Health Organization (WHO), CVDs are the premier cause of global deaths, killing nearly 17.9 million people worldwide in 2016. Atrial fibrillation (AF) is the most frequent and the most commonly observed CVD. For example, the American Heart Association estimates that AF af...

  The global  Spinal Muscular Atrophy Treatment Market  size is expected to reach  USD 14.49 billion by 2026 , exhibiting a  CAGR of 28.9%  during the forecast period. The rising prevalence of rare diseases around the world will fuel demand for SMA treatment in the forthcoming years, which in turn will aid the growth of the market. As per the National Policy for the treatment of rare diseases, globally, around 6000 to 8000 rare diseases are estimated to exist with new rare diseases reported on a regular basis. Furthermore, 80% of all the rare diseases are genetically originated and therefore impact children inexplicably. The survey also revealed that 50% of new cases are in children and are responsible for 35% of deaths before the age of 1 year, 10% between the ages of 1 and 5 years and 12% between 5 and 15 years. Nonetheless, “the growing initiatives by government authorities for pre-diagnosis will impact the Spinal Muscular Atrophy Treatment Market share ...

Fortune Business Insights™ veröffentlichte einen „  Idiopathic Inflammatory Myopathy Treatment Market  „Geschäftsanalyse- und Wachstumsprognose 2023-2030-Bericht, der die wichtigsten Wachstumschancen des Marktes beleuchtet. Dieser Bericht bietet eine gründliche Untersuchung des globalen Marktes für die Behandlung von idiopathischer entzündlicher Myopathie und identifiziert signifikante Trends in der Produkt-/Dienstleistungssegmentierung, Unternehmensgründung und Umsatz , Marktanteil, jüngste Fortschritte und MandA-Aktivität.Mit einem Schwerpunkt auf Marktportfolios und -fähigkeiten, Markteintrittsstrategien, Marktpositionen und geografischen Fußabdrücken analysiert dieser Bericht auch die Geschäftsstrategien internationaler Top-Unternehmen, um den Lesern zu helfen, die spezifischen Positionen besser zu verstehen die diese Unternehmen im expandierenden globalen Markt für die Behandlung von idiopathischer entzündlicher Myopathie halten.   Die globale Marktgröße für die Beha...

 The global idiopathic inflammatory myopathy treatment market size is projected to reach USD 930.6 million by 2026, thereby exhibiting a CAGR of 4.6% during the forecast period. However, the market was worth USD 652.3 million in 2018. Fortune Business Insights™ published this information in an upcoming report, titled, “Idiopathic Inflammatory Myopathy Treatment Market Size, Share and Industry Analysis, By Disease Type (Dermatomyositis (DM), Polymyositis (PM), Inclusion Body Myositis (IBM), Necrotizing Autoimmune Myopathy (NAM), Others), By Treatment (Corticosteroids, Immunosuppressants, Intravenous Immunoglobulins, Others), By Route of Administration (Oral, Intravenous, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026.” Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/idiopathic-inflammatory-myopathy-treatment-market-100198 Highlights...